Health-related quality of life in chronic hepatitis B patients

Hepatology

Volumn 47, Issue 4, 2008, Pages 1108-1117

  Siew, Chin Ong ^a   Mak, Belinda ^b   Myat, Oo Aung ^c   Li, Shu Chuen ^a,d   Lim, Seng Gee ^b,c,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS B; HUMAN; HYPERTENSION; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; PATIENT ASSESSMENT; PHYSICAL CAPACITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SHORT FORM 36; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HEPATITIS B; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 42249095614     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22138     Document Type: Article

References (41)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatol 2004;11:97-107.
2. Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682-1683.
3. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34(Suppl 1):S1-S3.
4. Incidence of acute hepatitis B - United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004;52:1252-1254.
5. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-125.
6. Carithers RL Jr, Sugano D, Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci 1996;41:75S-80S.
7. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE Jr. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998;7:39-55.
8. Ware JE, Jr., Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. HEPATOLOGY 1999;30:550-555.
9. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. HEPATOLOGY 1999;30:1299-1301.
10. Schipper H, Clinch JJ, Olweny CLM. Quality of life studies: Definitions and conceptual issues. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. New York: Lippincott-Raven; 1996:11-23.
11. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003;23:47-58.
12. Bruix J, Sherman M. Management of hepatocellular carcinoma. HEPATOLOGY 2005;42:1208-1236.
13. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992;305:160-164.
14. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-925.
15. Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health status measures in outpatient dialysis: early experiences in developing an outcomes assessment program. Med Care 1992;30:MS136-149.
16. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 1993;306:1440-1444.
17. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
18. McHorney CA, Ware JE, Jr., Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
19. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
20. Thumboo J, Fong KY, Machin D, Chan SP, Soh CH, Leong KH, et al. Quality of life in an urban Asian population: the impact of ethnicity and socio-economic status. Soc Sci Med 2003;56:1761-1772.
21. Ware JEJ, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A user's manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
22. Thumboo J, Fong KY, Ng TP, Leong KH, Feng PH, Boey ML. Initial construct cross-cultural validation of the Short Form 36 for quality of life assessment of systemic lupus erythematosus patients in Singapore. Ann Acad Med Singapore 1997;26:282-284.
23. Thumboo J, Fong KY, Machin D, Chan SP, Leon KH, Feng PH, et al. A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore. Qual Life Res 2001;10:175-188.
24. Thumboo J, Fong KY, Ng TP, Leong KH, Feng PH, Thio ST, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999;26:97-102.
25. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-343.
26. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al. Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003;12:87-92.
27. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, et al. Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore 2003;32:685-690.
28. Cramer JA, Spilker B: Pharmacoeconomics. In: Cramer JA, Spilker B, eds. Quality of Life and Pharmacoeconomics: An Introduction. Philadelphia, PA: Lippincott-Raven; 1998:221-264.
29. Thumboo J, Fong KY, Chan SP, Machin D, Feng PH, Thio ST, et al. The equivalence of English and Chinese SF-36 versions in bilingual Singapore Chinese. Qual Life Res 2002;11:495-503.
30. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al. Do English and Chinese EQ-5D versions demonstrate measurement equivalence? an exploratory study. Health Qual Life Outcomes 2003;1:7.
31. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. HEPATOLOGY 1998;27:209-212.
32. Gallegos-Orozco JF, Fuentes AP, Gerardo Argueta J, Perez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso MS, et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003;34:124-129.
33. von Wagner M, Lee JH, Kronenberger B, Friedl R, Sarrazin C, Teuber G, et al. Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels. J Viral Hepatol 2006;13:828-834.
34. Alonso J, Ferrer M, Gandek B, Ware JE, Jr., Aaronson NK, Mosconi P, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 2004;13:283-298.
35. Wai CT, Mak B, Chua W, Lim SG. The majority of hepatitis B carriers are not on regular surveillance in Singapore. Singapore Med J 2004;45:423-426.
36. Wai CT, Mak B, Chua W, Tan MH, Ng S, Cheok A, et al. Misperceptions among patients with chronic hepatitis B in Singapore. World J Gastroenterol 2005;11:5002-5005.
37. Guyatt G, Bombardier C, Tungwell P. Measuring disease specific quality of life in clinical trials. Can Med Assoc J 1986;134:889-895.
38. Fowlie M, Berkeley J. Quality of life, a review of the literature. Family Practice 1987;4:226-234.
39. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instrument. J Chron Dis 1987;40:171-178.
40. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-780.
41. Wai CT, Wong ML, Ng S, Cheok A, Tan MH, Chua W, Mak B, et al. Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B. Aliment Pharmacol Ther 2005;21:1255-1262.